Shell Asset Management CO Zai Lab LTD Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Zai Lab LTD stock. As of the latest transaction made, Shell Asset Management CO holds 191 shares of ZLAB stock, worth $5,135. This represents 0.0% of its overall portfolio holdings.

Number of Shares

191

Previous 191 -0.0%

Holding current value

$5,135

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 31, 2024	SELL	$15.95 - $26.8 $85,476 - $143,621	-5,359 Reduced 96.56%	191 $3,000
Q1 2024 May 14, 2024	SELL	$15.95 - $26.8 $4,290 - $7,209	-269 Reduced 4.62%	5,550 $89,000
Q4 2023 Feb 14, 2024	SELL	$22.97 - $30.58 $61,008 - $81,220	-2,656 Reduced 31.34%	5,819 $159,000
Q3 2023 Nov 08, 2023	BUY	$22.72 - $31.49 $14,813 - $20,531	652 Added 8.33%	8,475 $206,000
Q2 2023 Jul 28, 2023	SELL	$25.3 - $39.67 $46,526 - $72,953	-1,839 Reduced 19.03%	7,823 $217,000
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $42,294 - $67,340	1,400 Added 16.95%	9,662 $321,000
Q4 2022 Feb 07, 2023	SELL	$22.28 - $38.71 $51,244 - $89,033	-2,300 Reduced 21.78%	8,262 $254,000
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $253,080 - $382,506	-7,400 Reduced 41.2%	10,562 $361,000
Q2 2022 Aug 09, 2022	SELL	$23.14 - $49.68 $6,942 - $14,904	-300 Reduced 1.64%	17,962 $623,000
Q1 2022 May 04, 2022	SELL	$27.77 - $64.4 $74,979 - $173,880	-2,700 Reduced 12.88%	18,262 $803,000
Q4 2021 Feb 09, 2022	BUY	$54.9 - $105.21 $16,470 - $31,562	300 Added 1.45%	20,962 $1.32 Million
Q3 2021 Nov 04, 2021	SELL	$105.0 - $178.37 $325,500 - $552,947	-3,100 Reduced 13.05%	20,662 $2.18 Million
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $625,550 - $900,000	5,000 Added 26.65%	23,762 $4.21 Million
Q1 2021 May 10, 2021	BUY	$126.27 - $191.71 $12,627 - $19,171	100 Added 0.54%	18,762 $2.5 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $518,434 - $856,296	6,327 Added 51.29%	18,662 $2.53 Million
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $58,493 - $71,405	798 Added 6.92%	12,335 $1.03 Million
Q2 2020 Aug 10, 2020	BUY	$48.82 - $82.53 $272,806 - $461,177	5,588 Added 93.93%	11,537 $948,000
Q1 2020 May 11, 2020	BUY	$39.1 - $62.9 $232,605 - $374,192	5,949 New	5,949 $306,000

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.63B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Zai Lab LTD Transaction History